WAC 246-305-030
Conflict of interest. (1) An IRO:
(a) Must not be a subsidiary of, or in any way owned or
controlled by, a carrier or an association of health care
providers or carriers;
(b) Shall provide information to the department
on its own organizational affiliations and potential conflicts
of interest at the time of application and when material
changes occur;
(c) Shall immediately turn down a case referred
by the insurance commissioner if accepting it would constitute
an organizational conflict of interest; and
(d) Shall ensure that reviewers are free from
any actual or potential conflict of interest in assigned
cases.
(2) An IRO, as well as its reviewers, must not have any
material familial, professional, or financial
affiliation, as defined in WAC 246-305-010, with the health
carrier, enrollee, enrollee's provider, that provider's
medical or practice group, the facility at which the service
would be provided, or the developer or manufacturer of a drug
or device under review. An affiliation with any director,
officer or executive of an IRO must be considered to
be an affiliation with the IRO.
(3) The following do not constitute violations of this
section:
(a) Staff affiliation with an academic medical center or
National Cancer Institute-designated clinical cancer research
center;
(b) Staff privileges at a health care facility;
(c) Maintaining a provider contract with a carrier which
provides no more than five percent of the provider's or
clinical group's annual revenue; or
(d) An IRO's receipt of a carrier's payment for
independent reviews assigned by the insurance commissioner
under RCW 48.43.535.
(4) Notwithstanding the provisions of subsection (3) of
this section, a potential reviewer must be
considered to have a conflict of interest with regard to a
facility or health plan, regardless of revenue from that
source, if the potential reviewer is a member of a standing
committee of: The facility, the health plan, or a provider
network that contracts with the health plan.
(5) A conflict of interest may be waived only if both the
enrollee and the health plan agree in writing after receiving
full disclosure of the conflict, and only if:
(a) The conflict involves a reviewer, and no alternate
reviewer with necessary special expertise is available; or
(b) The conflict involves an IRO and the insurance
commissioner determines that seeking a waiver of conflict is
preferable to reassigning the review to a different IRO.
[Statutory Authority: RCW 43.70.235 and 48.43.535. 11-23-124, § 246-305-030, filed 11/21/11, effective 11/26/11;
01-08-023, § 246-305-030, filed 3/28/01, effective 4/28/01.]